Evidence map›Paper›PMID 32891146›Full record

ReviewJournal of nanobiotechnology2020

How can nanotechnology help to combat COVID-19? Opportunities and urgent need.

Estefânia V R Campos, Anderson E S Pereira, Jhones Luiz de Oliveira, Lucas Bragança Carvalho, Mariana Guilger-Casagrande, Renata de Lima, Leonardo Fernandes Fraceto

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of nanobiotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Innovative applications of advanced nanomaterials in cerebrovascular imaging.Frontiers in bioengineering and biotechnology · 2024
    Review
  9. Biomedical Approach of Nanotechnology and Biological Risks: A Mini-Review.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Estefânia V R CamposHuman and Natural Sciences Center, Federal University of ABC. Av. dos Estados, 5001. Bl. A, T3 Lab. 503-3. Bangú, Santo André, SP, Brazil.
Anderson E S PereiraSão Paulo State University-UNESP, Institute of Science and Technology, Sorocaba, SP, Brazil.
Jhones Luiz de OliveiraSão Paulo State University-UNESP, Institute of Science and Technology, Sorocaba, SP, Brazil.
Lucas Bragança CarvalhoSão Paulo State University-UNESP, Institute of Science and Technology, Sorocaba, SP, Brazil.
Mariana Guilger-CasagrandeUniversidade de Sorocaba, Rodovia Raposo Tavares km 92,5, Sorocaba, São Paulo, Brazil.
Renata de LimaUniversidade de Sorocaba, Rodovia Raposo Tavares km 92,5, Sorocaba, São Paulo, Brazil. renata.lima@prof.uniso.br.
Leonardo Fernandes FracetoSão Paulo State University-UNESP, Institute of Science and Technology, Sorocaba, SP, Brazil. leonardo.fraceto@unesp.br.

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior CAPES-COFECUB 88887.363975/2019-00Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/21004-5Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/24402-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/21142-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/23608-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/05100-1
6 · The paper itself

Abstract

Incidents of viral outbreaks have increased at an alarming rate over the past decades. The most recent human coronavirus known as COVID-19 (SARS-CoV-2) has already spread around the world and shown R

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralAntiviral AgentsClinical Laboratory TechniquesCOVID-19COVID-19 TestingCOVID-19 VaccinesDisinfectionDrug CarriersDrug Delivery SystemsHumansNanostructuresNanotechnologyPersonal Protective EquipmentAntiviral AgentsCOVID-19 VaccinesDrug CarriersViral VaccinesCoronavirusNanoparticlesNanosensorsNanotechnologyNano-vaccinesSARS-CoV-2

Identifiers

PMID32891146
PMCPMC7474329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.